These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37396626)

  • 21. Corrigendum to "The role of rankings in higher education policy: Coercive and normative isomorphism in Kazakhstani higher education" [Int. J. Educ. Dev. 78 (2020) 1-13].
    Anafinova S
    Int J Educ Dev; 2021 Jan; 80():102293. PubMed ID: 34720382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Corrigendum to "Exposure of vaccinated and naive cattle to natural challenge from buffalo-derived Theileria parva" [Int. J. Parasitol. Parasites Wildl. 4(2) (2015) 244-251].
    Sitt T; Poole EJ; Ndambuki G; Mwaura S; Njoroge T; Omondi GP; Mutinda M; Mathenge J; Prettejohn G; Morrison WI; Toye P
    Int J Parasitol Parasites Wildl; 2017 Dec; 6(3):219. PubMed ID: 29988829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Corrigendum to "Exploring social movement concepts and actions in a knowledge uptake and sustainability context: A concept analysis" [Int J Nurs Sci 9/4 (2022) 411-421].
    Grinspun D; Wallace K; Li SA; McNeill S; Squires JE; Bujalance J; D'Arpino M; De Souza G; Farshait N; Gabbay J; Graham ID; Hutchinson A; Kinder K; Laur C; Mah T; Moore JE; Plant J; Ploquin J; Ruiter PJA; St-Germain D; Sills-Maerov M; Tao M; Titler M; Zhao J
    Int J Nurs Sci; 2023 Apr; 10(2):e1. PubMed ID: 37128483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Corrigendum to "Leveraging data analytics to understand the relationship between restaurants' safety violations and COVID-19 transmission" [Int. J. Hosp. Manag. 104 (2022) 103241].
    Huang A; de la Mora Velasco E; Farhangi A; Bilgihan A; Jahromi MF
    Int J Hosp Manag; 2022 Oct; 107():103328. PubMed ID: 36091184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Corrigendum to "Development of intranasal implantable devices for schizophrenia treatment" [Int. J. Pharm. 624 (2021) 122061].
    Utomo E; Domínguez-Robles J; Moreno-Castellanos N; Stewart SA; Picco CJ; Anjani QK; Simón JA; Peñuelas I; Donnelly RF; Larrañeta E
    Int J Pharm; 2023 Jan; 630():122475. PubMed ID: 36517342
    [No Abstract]   [Full Text] [Related]  

  • 26. Corrigendum to "Molecular insights and novel approaches for targeting tumor metastasis" [Int. J. Pharm. 585 (2020) 119556].
    Das SS; Alkahtani S; Bharadwaj P; Ansari MT; ALKahtani MDF; Pang Z; Hasnain MS; Nayak AK; Aminabhavi TM
    Int J Pharm; 2020 Nov; 590():119967. PubMed ID: 33071034
    [No Abstract]   [Full Text] [Related]  

  • 27. Corrigendum to "Emergency decompression and stabilization of 1st thoracic spinal cord injury and sacral fracture in a Covid-19 patient: A case report" [Int. J. Surg. 81 (2021) 105670].
    Surachman AJD; Yanuarso ; Akbar DL
    Int J Surg Case Rep; 2021 Aug; 85():106162. PubMed ID: 34294594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Corrigendum to "Regional variations in baseline characteristics of cardiac rhythm device recipients: The PANORAMA observational cohort study" [Int. J. Cardiol. Heart Vessels (2014) 90-96].
    Al Kandari F; Erglis A; Sweidan R; Dannheimer I; Sepsi M; Bénézet J; Padour M; Naik A; Escudero J; West T; Holbrook R; Lorgat F;
    Int J Cardiol Heart Vasc; 2016 Sep; 12():95. PubMed ID: 31265719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Corrigendum to "Powder cohesion and energy to break an avalanche: Can we address surface heterogeneity?" [Int. J. Pharm. 626 (2022) 122198].
    Brokešová J; Niederquell A; Kuentz M; Zámostný P; Vraníková B; Šklubalová Z
    Int J Pharm; 2023 Jan; 631():122485. PubMed ID: 36529577
    [No Abstract]   [Full Text] [Related]  

  • 30. Corrigendum to "Topical delivery of aqueous micellar Resolvin E1 analog (RX-10045)" [Int. J. Pharm. 498 (2016) 326-334].
    Cholkar K; Gilger BC; Mitra AK
    Int J Pharm; 2016 Jul; 509(1-2):528. PubMed ID: 27350413
    [No Abstract]   [Full Text] [Related]  

  • 31. Corrigendum to "Nanocarrier-based dermopharmaceutical formulations for the topical management of atopic dermatitis" [Int. J. Pharm. 618 (2022) 121656].
    Paiva-Santos AC; Gama M; Peixoto D; Sousa-Oliveira I; Ferreira-Faria I; Zeinali M; Abbaspour-Ravasjani S; Mascarenhas-Melo F; Hamishehkar H; Veiga F
    Int J Pharm; 2022 Nov; 627():122146. PubMed ID: 36167592
    [No Abstract]   [Full Text] [Related]  

  • 32. Corrigendum to "The effect of misoprostol on the removal of endometrial polyps: A pilot clinical trial" [Int J Reprod BioMed 2022; 20: 461-468].
    Aflatoonian A; Pezeshkpour Z; Mehrolhasani Y; Tabibnejad N
    Int J Reprod Biomed; 2022 Dec; 20(12):1055. PubMed ID: 36819205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corrigendum to "A review on 5-aminosalicylic acid colon-targeted oral drug delivery systems" [Int. J. Pharm. 558 (2019) 367-379].
    Shahdadi Sardo H; Saremnejad F; Bagheri S; Akhgari A; Afrasiabi Garekani H; Sadeghi F
    Int J Pharm; 2022 Nov; 628():122312. PubMed ID: 36323128
    [No Abstract]   [Full Text] [Related]  

  • 34. Corrigendum to "Transdermal delivery of vancomycin hydrochloride: Influence of chemical and physical permeation enhancers" [Int. J. Pharm. 602 (2021) 120663].
    Datta D; Panchal DS; Venuganti VVK
    Int J Pharm; 2021 Nov; 609():121171. PubMed ID: 34635371
    [No Abstract]   [Full Text] [Related]  

  • 35. Corrigendum to "Personalised urethra pessaries prepared by material extrusion-based additive manufacturing" [Int. J. Pharm. 608 (2021) 121112].
    Spoerk M; Arbeiter F; Koutsamanis I; Cajner H; Katschnig M; Eder S
    Int J Pharm; 2023 Jan; 631():122548. PubMed ID: 36585325
    [No Abstract]   [Full Text] [Related]  

  • 36. Corrigendum to "Triboelectrification: A review of experimental and mechanistic modeling approaches with a special focus on pharmaceutical powders" [Int. J. Pharm. 510 (2016) 375-385].
    Naik S; Mukherjee R; Chaudhuri B
    Int J Pharm; 2016 Oct; 512(1):329. PubMed ID: 27646923
    [No Abstract]   [Full Text] [Related]  

  • 37. Corrigendum to "Development and assessment of phospholipid-based luteolin-loaded lipid nanocapsules for skin delivery" [Int. J. Pharm. 629 (2022) 122375].
    Elmowafy M; Shalaby K; Elkomy MH; Alsaidan OA; Gomaa HAM; Abdelgawad MA; Massoud D; Salama A; El-Say KM
    Int J Pharm; 2023 Mar; 635():122782. PubMed ID: 36858890
    [No Abstract]   [Full Text] [Related]  

  • 38. Corrigendum to "Development of silymarin topical formulation: In vitro and ex vivo dermal kinetics of silymarin" [Int. J. Pharm. 63 (2023) 122431].
    Shankar VK; Police A; Ajjarapu S; Murthy SN
    Int J Pharm; 2023 Mar; 635():122590. PubMed ID: 36890040
    [No Abstract]   [Full Text] [Related]  

  • 39. Corrigendum to "Fabrication of microporous inorganic microneedles by centrifugal casting method for transdermal extraction and delivery" [Int. J. Pharm. 558 (2019) 299-310].
    Gholami S; Mohebi MM; Hajizadeh-Saffar E; Ghanian MH; Zarkesh I; Baharvand H
    Int J Pharm; 2021 Sep; 606():120890. PubMed ID: 34389200
    [No Abstract]   [Full Text] [Related]  

  • 40. Corrigendum to "Formulation and characterization of self-nanoemulsifying drug delivery systems containing monoacyl phosphatidylcholine" [Int. J. Pharm. 502 (1-2) (2016) 151-160].
    Tran T; Xi X; Rades T; Müllertz A
    Int J Pharm; 2016 Jun; 507(1-2):109. PubMed ID: 27241782
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.